Performance of Marker-less Tracking for Gimbaled Dynamic Tumor Tracking (2019) Ziegler M, Lettmaier S, Fietkau R, Bert C Conference contribution Is adaptive treatment planning in multi-catheter interstitial breast brachytherapy necessary? (2019) Kallis K, Ziegler M, Lotter M, Kreppner S, Strnad V, Fietkau R, Bert C Journal article Estimation of inter-fractional variations in interstitial multi-catheter breast brachytherapy using a hybrid treatment delivery system (2019) Kallis K, Abu-Hossin N, Kreppner S, Lotter M, Strnad V, Fietkau R, Bert C Journal article Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy (2019) Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, et al. Journal article Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology (2018) Combs SE, Farzin M, Boehmer J, Oehlke O, Molls M, Debus J, Grosu AL Journal article Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC (2018) Linge A, Schoetz U, Loeck S, Lohaus F, Von Neubeck C, Gudziol V, Nowak A, et al. Journal article Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis (2018) Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, Gruen A, et al. Journal article SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy (2018) De-Colle C, Menegakis A, Moennich D, Welz S, Boeke S, Sipos B, Fend F, et al. Journal article QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Conference contribution